CBD Science looks to raise £2M in Series A to advance its plant-based cannabinoid therapy in the UK September 24, 2021 admin CBD 0 CBD Science Group PLC CEO Dr Michael Raymont joined Proactive New York to discuss the London, England-based group’s Series A funding round, on the …
Be the first to comment